Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs PSA✓SelectedUSD · PSAMRNA vs PSA performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs PSA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+147.0%
PSA return
+42.7%
Excess return
+104.3%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioPSAExcessAlpha
1D-2.2%-0.4%-1.8%-2.0%
7D-12.7%-2.2%-10.5%-11.6%
30D-20.7%+9.1%-29.8%-24.5%
3M+46.3%+1.9%+44.4%+44.7%
6M+305.2%+9.6%+295.7%+282.7%
YTD+561.2%+29.2%+532.1%+467.8%
1Y+772.1%+27.7%+744.4%+653.2%
3Y+147.0%+42.3%+104.7%+78.3%
All+147.0%+42.7%+104.3%+78.3%

Cumulative growth

Daily Returns

Daily percentage return beside PSA.

Daily Out/Under-Performance

Portfolio return minus PSA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × PSA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded PSA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling